Missing Messages of Clinical Pharmacologic Survey on Inotropic Drug Use in Neonatal Critical Care.
Yun Cao,Ying Dong,Bo Sun
DOI: https://doi.org/10.1097/pcc.0000000000000916
2016-01-01
Pediatric Critical Care Medicine
Abstract:1004 www.pccmjournal.org October 2016 • Volume 17 • Number 10 The immaturity of cardiovascular system and disease status predispose newborn infants, both term and preterm, to low systemic blood flow during the first week of life and beyond, when various morbidities, including hypoxemic respiratory failure, patent ductus arteriosus (PDA), sepsis, necrotizing enterocolitis (NEC), hypoxic-ischemic injury, and persistent pulmonary hypertension of the newborn (PPHN), are likely to occur. Hemodynamic instability is associated with increased morbidities and mortality in neonates, and the consequences, diagnosis, and treatment of hemodynamic instability are important issues in neonatology. Inotropes with dopamine as the representative drug are commonly used in neonatal ICUs (NICUs). However, pharmaceutical activity of most inotropic drugs in newborns especially the very immature ones is largely unknown, and alternative drugs for dopamine are yet to be identified in order to achieve the goal hemodynamic status with minimal adverse effects (1). In this issue of Pediatric Critical Care Medicine, Burns et al (2) conducted a retrospective survey of inotropic drug (dopamine, dobutamine, epinephrine, norepinephrine, milrinone, and levosimedan) use in a large sample of 974 neonates from a Norwegian Neonatal Network, corresponding to 2.7% and 0.27%, respectively, of a total of 36,397 NICU admissions and a nearly complete live birth population of 361,803 from 2009 to 2014. Given the population-based nature of this study, the results may be applicable to future studies on neonatal inotropic use and outcomes. The authors analyzed the use of inotropic drug in three groups categorized by neonatal maturation, as well as the timing and mode of drug application. Consistent with other studies (3–6), this study demonstrated dopamine to be the most commonly used drug in all gestational age (GA) groups, either as monotherapy or in combination patients (7–10). The findings of Mahle et al (2) showed that the following principles were found to be essential for successful early extubation in pediatric cardiac surgery in all five participating centers. They were as follows: 1) choice and dose of premedication and anesthetic agents that would allow for early extubation; 2) anesthesia with volatile anesthetic with low-dose opioids and to my mind the most important factor and 3) balanced sedation/analgesia in the early postoperative period. The only drawback I want to mention is that the advantages of the described collaborative learning strategy to translate new published findings into clinical practice more rapidly might not be as fast as suggested by the authors. To bring 10 different institutions together at one table, to set up protocols to organize site visits, and to ensure ongoing communication might be time consuming. The study is not able to prove that without collaboration the same change in practice would naturally occur in the same time interval. Nevertheless, the “collaborative learning approach” seems to be a promising tool for increasing the rate of successful early extubation and fast-track protocol even in complex patients without a change in reintubation rate in infants following cardiac surgery. It could also be a template for other complex topics like change of preoperative fasting protocols in children or introducing procedural sedation just to name two as examples. REFERENCES 1. Grol R, Grimshaw J: From best evidence to best practice: Effective implementation of change in patients’ care. Lancet 2003; 362:1225–1230 2. Mahle WT, Nicolson SC, Hollenbeck-Pringle D, et al; for the Pediatric Heart Network Investigators: Utilizing a Collaborative Learning Model to Promote Early Extubation Following Infant Heart Surgery. Pediatr Crit Care Med 2016; 17:939–947 3. Vygotsky LS: Mind in Society: The Development of Higher Mental Process. Cambridge, MA, Harvard University Press, 1978 4. Agarwal BB, Chintamani, Agarwal S: Fast track surgery-minimizing side effects of surgery. Indian J Surg 2015; 77(Suppl 3):753–758 5. Ansari D, Gianotti L, Schröder J, et al: Fast-track surgery: Procedurespecific aspects and future direction. Langenbecks Arch Surg 2013; 398:29–37 6. Nanavati AJ, Prabhakar S: Fast-track surgery: Toward comprehensive peri-operative care. Anesth Essays Res 2014; 8:127–133 7. Mahle WT, Jacobs JP, Jacobs ML, et al: Early extubation after repair of tetralogy of Fallot and the Fontan procedure: An analysis of the society of thoracic surgeons congenital heart surgery database. Ann Thorac Surg 2016 May 9. [Epub ahead of print] 8. Mutsuga M, Quiñonez LG, Mackie AS, et al: Fast-track extubation after modified Fontan procedure. J Thorac Cardiovasc Surg 2012; 144:547–552 9. Alghamdi AA, Singh SK, Hamilton BC, et al: Early extubation after pediatric cardiac surgery: Systematic review, meta-analysis, and evidence-based recommendations. J Card Surg 2010; 25:586–595 10. Kawaguchi A, Liu Q, Coquet S, et al: Impact and challenges of a policy change to early track extubation in the operating room for Fontan. Pediatr Cardiol 2016 May 9. [Epub ahead of print]